DK0991424T3 - Farmaceutiske præparater omfattende en inhibitor for aldosereduktase og en inhibitor for ACE - Google Patents

Farmaceutiske præparater omfattende en inhibitor for aldosereduktase og en inhibitor for ACE

Info

Publication number
DK0991424T3
DK0991424T3 DK98932358T DK98932358T DK0991424T3 DK 0991424 T3 DK0991424 T3 DK 0991424T3 DK 98932358 T DK98932358 T DK 98932358T DK 98932358 T DK98932358 T DK 98932358T DK 0991424 T3 DK0991424 T3 DK 0991424T3
Authority
DK
Denmark
Prior art keywords
inhibitor
pharmaceutical compositions
aldose reductase
ace
reductase inhibitor
Prior art date
Application number
DK98932358T
Other languages
Danish (da)
English (en)
Inventor
Frank Carey
David Patrick Tuffin
Norman Eugene Cameron
Mary Anne Cotter
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK0991424T3 publication Critical patent/DK0991424T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98932358T 1997-07-08 1998-07-02 Farmaceutiske præparater omfattende en inhibitor for aldosereduktase og en inhibitor for ACE DK0991424T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714274.9A GB9714274D0 (en) 1997-07-08 1997-07-08 Pharmaceutical composition
PCT/GB1998/001959 WO1999002189A1 (en) 1997-07-08 1998-07-02 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor

Publications (1)

Publication Number Publication Date
DK0991424T3 true DK0991424T3 (da) 2001-12-03

Family

ID=10815469

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98932358T DK0991424T3 (da) 1997-07-08 1998-07-02 Farmaceutiske præparater omfattende en inhibitor for aldosereduktase og en inhibitor for ACE

Country Status (28)

Country Link
US (1) US6337327B1 (pt)
EP (1) EP0991424B1 (pt)
JP (1) JP2002509540A (pt)
KR (1) KR20010015551A (pt)
CN (1) CN1186097C (pt)
AT (1) ATE205402T1 (pt)
AU (1) AU746211B2 (pt)
BR (1) BR9810570A (pt)
CA (1) CA2292451A1 (pt)
CZ (1) CZ290276B6 (pt)
DE (1) DE69801661T2 (pt)
DK (1) DK0991424T3 (pt)
ES (1) ES2163283T3 (pt)
GB (1) GB9714274D0 (pt)
HK (1) HK1028876A1 (pt)
HU (1) HU224009B1 (pt)
ID (1) ID24597A (pt)
IL (1) IL133004A (pt)
NO (1) NO20000045D0 (pt)
NZ (1) NZ501165A (pt)
PL (1) PL337925A1 (pt)
PT (1) PT991424E (pt)
RU (1) RU2216354C2 (pt)
SK (1) SK122000A3 (pt)
TR (1) TR199903026T2 (pt)
UA (1) UA64761C2 (pt)
WO (1) WO1999002189A1 (pt)
ZA (1) ZA985993B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642268B2 (en) * 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6221897B1 (en) * 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
GB0001662D0 (en) * 1999-02-06 2000-03-15 Zeneca Ltd Pharmaceutical compositions
US6426341B1 (en) * 1999-06-30 2002-07-30 Pfizer Inc. Treatment for diabetic complications
AU2001238718A1 (en) * 2000-03-02 2001-09-12 The Institutes For Pharmaceutical Discovery, Llc Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US20050203169A1 (en) * 2001-08-06 2005-09-15 Moskowitz David W. Methods and compositions for treating diseases associated with excesses in ACE
WO2003013434A2 (en) * 2001-08-06 2003-02-20 Genomed, Llc Methods and compositions for treating diseases associated with excesses in ace
WO2003046165A1 (en) * 2001-11-26 2003-06-05 Bayer Healthcare Ag Regulation of human aldose reductase-like protein
US7071210B2 (en) * 2002-07-02 2006-07-04 Pfizer Inc. CETP inhibitors in combination with antihypertensive agents and uses thereof
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
PL2771003T3 (pl) 2011-10-28 2017-10-31 Lumena Pharmaceuticals Llc Inhibitory ponownego wykorzystania kwasów żółciowych do leczenia pediatrycznych cholestatycznych chorób wątroby
WO2014022291A1 (en) * 2012-07-28 2014-02-06 The Regents Of The University Of Colorado, A Body Corporate Compounds reducing the production of sorbitol in the eye and methods of using the same
CN103063794B (zh) * 2012-12-24 2014-08-06 扬子江药业集团南京海陵药业有限公司 一种依帕司他片的含量检测控制方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9016978D0 (en) 1990-08-02 1990-09-19 Ici Plc Acetamide derivatives
AU711482B2 (en) * 1994-06-28 1999-10-14 Scotia Holdings Plc Compositions for treatment of diabetic complications

Also Published As

Publication number Publication date
KR20010015551A (ko) 2001-02-26
ZA985993B (en) 1999-01-18
UA64761C2 (uk) 2004-03-15
CA2292451A1 (en) 1999-01-21
CN1186097C (zh) 2005-01-26
SK122000A3 (en) 2000-06-12
DE69801661D1 (de) 2001-10-18
AU746211B2 (en) 2002-04-18
PT991424E (pt) 2002-02-28
IL133004A (en) 2004-12-15
NO20000045L (no) 2000-01-06
CN1261804A (zh) 2000-08-02
ATE205402T1 (de) 2001-09-15
EP0991424A1 (en) 2000-04-12
CZ200017A3 (cs) 2000-05-17
NZ501165A (en) 2001-06-29
NO20000045D0 (no) 2000-01-06
DE69801661T2 (de) 2002-07-04
JP2002509540A (ja) 2002-03-26
HK1028876A1 (en) 2001-03-09
ES2163283T3 (es) 2002-01-16
PL337925A1 (en) 2000-09-11
TR199903026T2 (xx) 2000-04-21
CZ290276B6 (cs) 2002-06-12
AU8229698A (en) 1999-02-08
IL133004A0 (en) 2001-03-19
RU2216354C2 (ru) 2003-11-20
HU224009B1 (hu) 2005-04-28
EP0991424B1 (en) 2001-09-12
US6337327B1 (en) 2002-01-08
GB9714274D0 (en) 1997-09-10
BR9810570A (pt) 2000-09-19
HUP0002644A2 (hu) 2000-12-28
WO1999002189A1 (en) 1999-01-21
ID24597A (id) 2000-07-27

Similar Documents

Publication Publication Date Title
NO20061736L (no) Krystallform av epotilon B
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
DK0991424T3 (da) Farmaceutiske præparater omfattende en inhibitor for aldosereduktase og en inhibitor for ACE
TR200001451T2 (tr) Aldoz redüktaz önleyici ve glikojen fosforilaz önleyici kombinasyonu.
IL151313A0 (en) Lipase containing pharmaceutical compositions
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
EA200501805A1 (ru) Фармацевтическая композиция, содержащая ингибитор фермента дипептидилпептидазы
BR0108396A (pt) Derivados de pirimidina-4-0na como inibidores de ldl-pla(2)
TR200103493T2 (tr) Metaloproteaz önleyicileri
BR0215405A (pt) Composições e processos de uso de collajolie
NO20052380L (no) Beta-amino-heterosykliske dipeptidylpeptidaseinhibitorer for behandling og forhindring av diabetes
EA200401471A1 (ru) Применение ингибиторов сетр и возможных ингибиторов hmg coa и/или антигипертензивных агентов
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
FI962487A0 (fi) Rapamysiinijohdannaisia
PT935465E (pt) Compostos novos de imidazole substituido
ECSP055783A (es) Derivados de fenilalanina como inhibidores de dipeptidilpeptidasa para el tratamiento o prevención de diabetes
EP1385508A4 (en) DIPEPTIDYLPEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
DK1372650T3 (da) Kombinationer indeholdende et antidiarrémiddel og en epothilon eller et epothilonderivat
AR038207A1 (es) Composicion farmaceutica dispersable oralmente de agomelatina
BR0010220A (pt) Compostos de pirimidinona
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
JO1696B1 (en) Acetamide derivatives
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
AU4651700A (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases